An interventional study of PACO intervention for CABG patients and PACO intervention for AVR patients in Coronary Artery Disease, Aortic Valve Stenosis and Mitral Valve Insufficiency, sponsored by Kuopio University Hospital. Recruiting at 1 site in Finland. Open to participants aged 30 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-08-15.
Sponsored by Kuopio University Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 55 studies in Coronary Artery Disease with a site in Finland — 13 open to participants now, 18 under way, none of them phase 3. Coronary Artery Disease · Finland.
Among the 55 studies in Coronary Artery Disease with a site in Finland, this one is the 17th largest by planned enrollment of the 37 interventional ones that give a count, is one of 6 that started in 2018, is one of 21 with no phase, reaches primary completion later than 1 of the 17 other live ones, and was the 32nd registered.
4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.
Browse Coronary Artery Disease studies →13 of the 55 studies in Coronary Artery Disease with a site in Finland are open now. Recruiting first, the newest first:
Turku University Hospital · Sites in Finland
Ages 50–80
Tampere Heart Hospital · Sites in Finland
Ages 18+
Hospital District of Helsinki and Uusimaa · Sites in Finland
Ages 18–75
Spectrocor · Sites in Finland
Ages 18–90
University of Eastern Finland · Sites in Finland
Ages 18–100 · Healthy volunteers
A study can be open while its sites in Finland have not opened yet or have stopped. Only those recruiting at a site in Finland →
Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.
This study: 30 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
55 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 6 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 540 is above the median of 123 across 3,011 interventional studies indexed under Coronary Artery Disease.
Median enrollment 294 across the 37 interventional studies, 688 across the 18 observational. Of the 30 that completed or were terminated, 9 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
19 of 55 have an industry lead sponsor. The 10 most frequent:
Kuopio University Hospital is the lead sponsor of 135 studies on the registry; 24 are open to participants now.
Kuopio University Hospital has 3 studies filed under Coronary Artery Disease — fewer than ten, so there is no comparison to draw.
2 of the studies in Coronary Artery Disease with a site in Finland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03444259University of TurkuProspective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients | 2026-12-31 |
| NCT06084091SpectrocorSpectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 55 studies in Coronary Artery Disease with a site in Finland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The PACO trial is a randomized clinical trial conducted in Heart Centers of Kuopio and Turku university hospitals. The coronary artery disease, aortic valve stenosis and mitral valve insufficiency patients preparing for elective coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or mitral valve repair (MVR) will be randomized to either intervention or control group. The specific operation groups (CABG, AVR and MVR) will be analyzed separately. The 7-day baseline measurements of sedentary behaviour (SB), physical activity (PA) and sleep will be conducted to the patients by using the RM42 accelerometer during the pre-operative month.
After the cardiac procedure is completed and the patient is moved to post-operative ward, the control group patients will begin the standard post-operative rehabilitation program of the participating hospitals (activity guidance given by a physiotherapist). Patients in the intervention groups will follow the identical program but after discharge they will also receive personalized activity guidance through the combination of ExSed smart phone application, Suunto MoveSense accelerometer and cloud system during the first 90 days of post-operative rehabilitation. Weekly evolving daily goals to replace SB with PA (daily goals for steps, moderate PA, light PA and standing, and sitting time limit) will be designed for each patient of the intervention groups. A new daily step goal will be delivered from the cloud system to the patient's smart phone in the beginning of each week of the intervention. The daily step goal of the first intervention week is based on patient's walking distance assessed by a physiotherapist in post-operative ward. The following goals will be automatically evolved in the basis of patient's personal average step count of the previous week. The MoveSense accelerometer will measure accumulated levels of SB, PA and sleep, and transmit the data to user's ExSed application with Bluetooth. With information about accumulated levels of SB and PA, the application is able to guide the patient to accomplish the predefined activity goal. The guidance and motivation will be offered with pop-up notifications and histograms (columns are fulfilled according to patient's accumulated daily activity). The researches retain a remote access to the activity data of patients in the cloud system. The ExSed application will be connected to the cloud system with internet connection.
In addition, the patients of the intervention groups will receive short video files (lasting from 1 to 3 minutes) containing exercise guidance from a physiotherapist specialized to cardiac operation patients. These videos are available on the ExSed application during the intervention. The physiotherapist will also contact each patient (by mobile phone) with structured contact form from 1 to 4 times in a month to make sure that the intervention is proceeding as designed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The group of coronary artery disease patients receiving the standard postoperative rehabilitation of Kuopio and Turku university hospitals after coronary artery bypass grafting. The post-operative rehabilitation includes written and oral physical activity guidance from a physiotherapist.
The group of coronary artery disease patients receiving the PACO intervention for CABG patients besides the standard postoperative rehabilitation of Kuopio and Turku university hospitals after coronary artery bypass grafting. The PACO intervention includes activity guidance (i.e. goals to improve daily steps and physical activity levels, and reduce prolonged sitting) provided to the patients with the novel combination of ExSed application, MoveSense accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be included to the intervention.
Behavioral: PACO intervention for CABG patients
The group of aortic valve stenosis patients receiving the standard postoperative rehabilitation of Kuopio and Turku university hospitals after aortic valve replacement. The post-operative rehabilitation includes written and oral physical activity guidance from a physiotherapist.
The group of aortic valve stenosis patients receiving the PACO intervention for AVR patients besides the standard postoperative rehabilitation of Kuopio and Turku university hospitals after aortic valve replacement. The PACO intervention includes activity guidance (i.e. goals to improve daily steps and physical activity levels, and reduce prolonged sitting) provided to the patients with the novel combination of ExSed application, MoveSense accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be included to the intervention.
Behavioral: PACO intervention for AVR patients
The group of mitral valve insufficiency patients receiving the standard postoperative rehabilitation of Kuopio and Turku university hospitals after mitral valve repair. The post-operative rehabilitation includes written and oral physical activity guidance from a physiotherapist.
The group of mitral valve insufficiency patients receiving the PACO intervention for MVR patients besides the standard postoperative rehabilitation of Kuopio and Turku university hospitals after mitral valve repair. The PACO intervention includes activity guidance (i.e. goals to improve daily steps and physical activity levels, and reduce prolonged sitting) provided to the patients with the novel combination of ExSed application, MoveSense accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be included to the intervention.
Behavioral: PACO intervention for MVR patients
The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from coronary artery bypass grafting (CABG). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.
The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from aortic valve replacement (AVR). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.
The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from mitral valve repair (MVR). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.
Improvement in mean daily number of steps
The improvement in mean daily number of steps after 3 months from discharge. In addition, the follow-up will be continued until 12 months after discharge. The baseline values of mean daily number of steps will be determined in a 7-day accelerometer measurements conducted to the patients before the elective cardiac operation. The mean daily number of steps after the first 3 and 12 months of post-operative rehabilitation at home will be also determined in 7-day (24 h) accelerometer measurements. The raw accelerometer data will be analyzed with Mean Amplitude Deviation and Angle for Posture Estimation -algorithms to recognize the daily steps for the 7 days of which average will be calculated for each study patient.
Time frame: Improvement between baseline (during the last preoperative month) and first 3 (and 12) months after discharge.
Change in mean daily accumulated total time of light PA and MVPA
The post-operative change in patient's mean daily accumulated total time of light and moderate to vigorous physical activity.
Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.
Change in mean daily total time of sedentary behaviour (SB)
The post-operative change in patient's mean daily total time of SB.
Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.
Change in maximal oxygen consumption
The evolvement of patient's maximal oxygen consumption (VO2 peak) will be determined in 6 minute walking test, conducted to the patients twice (after 1 and 3 months) post-operatively. Only a part of the randomized patients coming from city areas of Kuopio and Turku will be included to the measurements of maximal oxygen consumption.
Time frame: Change between the first and third months after discharge.
Improvement in self-perceived quality of life (QoL) assessed with SAQ-7 -questionnaire
The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with Seattle Angina Questionnaire 7 (SAQ-7).
Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.
Improvement in self-perceived quality of life (QoL) assessed with SF-36 -questionnaire
The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with SF-36 -questionnaire.
Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.
Improvement in self-perceived quality of life (QoL) assessed with 15 D -questionnaire
The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with 15 D -questionnaire.
Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.
Improvement in self-perceived quality of life (QoL) assessed with PHQ-2 -questionnaire
The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with PHQ-2 -questionnaire.
Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.
Improvement in self-perceived quality of life (QoL) assessed with Rose Dyspnea Index
The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with Rose Dyspnea Index.
Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.
Incidence of major cardiovascular events
The major cardiovascular events include: all-cause mortality, any rehospitalizations due to CVD, repeat coronary revascularization, non-operational myocardial infarction and stroke. The incidence of major cardiovascular events will be monitored from the patient records of the hospitals and HILMO database during the first 12 post-operative months. In addition, patients will be asked about cardiovascular events during research telephone contact (after 12 months of rehabilitation).
Time frame: The first 12 post-operative months
Change in the accelerometer-derived portion of deep sleep
The change in patient's deep sleep portion after cardiac operations. Deep sleep will be recognized with accelerometer attached to patient's wrist during sleep. Accelerometer will be used during 7 days.
Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.
Change in heart rate variability
The change in the heart rate variability.
Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.
Plan to share: No
Started Apr 2018 (actual). Primary completion is estimated for Jan 2022, 45 months after the start.
Of 756 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 45 months is above that.
Counting every sponsor, half of 933 studies reached it within 30 months; a quarter within 15 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.